Anvisa suspends sale of drug batch to treat HIV
Two lots of Kaletra drug, used to treat HIV infection, had the import, distribution and sales suspended by the National Health Surveillance Agency (Anvisa).
The determination goes for lots 1042956 and 1055165 100 of Kaletra milligrams.
It is a complex situation and, although I do not know if there is a risk of shortage, I suggest you verificasse the batch number and, if necessary, return to the place where you take the medication and ask the exchange.
Just in case (most of the time we who are in treatment, we know of things more than they, those who "take care" of us), I advise you to print this article or light page address to the health professional may know that the issue is serious and you may be taking an expired medicine.
The origin of this news and the Agency Brazil.
More information about Kaletra
Kaletra - Remedy bull
Kaletra with dosage, indications, side effects, interactions and other information. All information contained in the leaflet Kaletra They are intended to inform and educate, not intended, in any way, replace the advice of a medical professional or serve as a recommendation for any type of treatment. Decisions regarding the treatment of patients with Kaletra They should be taken by authorized personnel, considering the characteristics of each patient.